Nitric Oxide Versus Prostaglandin E1 for Reduction of Pulmonary Hypertension in Heart Transplant Candidates
- 30 June 2005
- journal article
- clinical trial
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (6) , 690-695
- https://doi.org/10.1016/j.healun.2004.04.016
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pulmonary HypertensionArchives of internal medicine (1960), 2002
- Inhaled Nitric OxideAnesthesiology, 1999
- Reversibility of pulmonary hypertension in patients evaluated for orthotopic heart transplantation: importance in the postoperative morbidity and mortalityTransplantation Proceedings, 1999
- Does Preexisting Elevated Pulmonary Vascular Resistance (Transpulmonary Gradient >15 mm Hg or >5 Wood) Predict Early and Long-Term Results After Orthotopic Heart Transplantation?Transplantation Proceedings, 1998
- Reevaluating the significance of pulmonary hypertension before cardiac transplantation: Determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortalityThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Effect of Prostaglandin E 1 Infusion in Severe Chronic Heart FailureProstaglandins, 1997
- Prostaglandin E1--bridge to cardiac transplantation: Technique, dosage, resultsEuropean Heart Journal, 1997
- Prostaglandins in Heart TransplantationPublished by Springer Nature ,1997
- Hemodynamic effects of inhaled nitric oxide in heart failureJournal of the American College of Cardiology, 1994
- Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: Comparative effects of various pharmacologic agentsAmerican Heart Journal, 1991